LYPD5 and cancer: The classical NF-κB heterodimer (p50/p65) modulates cancer hallmarks such as cell proliferation, evasion of apoptosis, and metastasis via inducing expression of proliferating, anti-apoptotic, and metastasis-associated proteins encoded by NF-κB target oncogenes [30,31].